Humana Inc. (HUM)
Health Care4 articles
Price chart
Humana Inc. (HUM) overview
Humana is a large U.S. health insurer focused on Medicare Advantage. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
Humana Inc. trades on the NYSE under the ticker symbol HUM. As of the most recent market data, the stock was priced around $400.00, up 3.50% on the session.
Over the past 52 weeks, HUM has traded between $163.11 and $428.88. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 42.7, a common gauge of how richly the market prices the company's earnings. Humana Inc. also pays a dividend, currently yielding around 89.00%.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch HUM
As one of the larger companies in the Health Care sector, Humana Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch HUM for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest HUM news
Humana (HUM) Stock Surges Amid Positive Market Reactions
Humana (HUM) saw an increase in stock price, attributed to favorable market conditions. While specific metrics such as percentage increases or trading volumes were not disclosed, the surge indicates positive investor sentiment towards the company. The movement may suggest increasing confidence in Humana's financial performance. Monitoring the stock's trajectory will be essential for understanding its ongoing influence in the health insurance sector.
Read More: Humana (HUM) Stock Surges Amid Positive Market Reactions
US Health Insurers Surge on Medicare Payments Increasing 2.48%
US health insurers, including Humana (HUM), UnitedHealth Group (UNH), and CVS Health (CVS), saw their stocks rise following a Medicare Advantage payment increase. The Centers for Medicare & Medicaid Services (CMS) announced a net average increase of 2.48% in payments for 2027, up from a previously proposed 0.9%. This adjustment is projected to add approximately $13 billion in revenue to private insurers. The higher payments are aimed at providing financial relief amid rising medical costs, with Humana shares rising 6.4%, UnitedHealth by 8.8%, and CVS by 6.6%.
Read More: US Health Insurers Surge on Medicare Payments Increasing 2.48%
UnitedHealth (UNH) and Humana (HUM) Stocks Rise on Medicare Payment Boost
Shares of UnitedHealth (UNH) and Humana (HUM) have increased following the announcement that the Trump administration will raise subsidies for certain Medicare programs. This increase in payments is expected to enhance profitability for these health insurers, which are crucial players in the healthcare market. Investors are likely reacting positively to the anticipated financial benefits from these changes. As healthcare companies stand to gain from the boost in subsidies, this development could attract more investments in the sector.
Read More: UnitedHealth (UNH) and Humana (HUM) Stocks Rise on Medicare Payment Boost
Trump Iran threat impacts markets amid Strait of Hormuz tensions
US President Trump has issued a warning concerning the Strait of Hormuz, stating that consequences will follow if it does not reopen within 48 hours. This statement comes amidst ongoing geopolitical tensions affecting global oil supplies. The Strait of Hormuz is a critical maritime passageway for oil shipments, and any disruptions could lead to price fluctuations in the oil market. Investors are advised to monitor developments closely as the situation may impact energy stocks and prices.
Read More: Trump Iran threat impacts markets amid Strait of Hormuz tensionsMore Health Care stocks
Frequently asked questions
Is Humana Inc. in the S&P 500?
Yes. Humana Inc. (HUM) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is HUM in?
Humana Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest HUM news?
This page collects recent Humana Inc. (HUM) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is Humana Inc.'s stock price?
As of the most recent market data, Humana Inc. (HUM) traded at approximately $400.00. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is HUM's P/E ratio?
HUM trades at a trailing price-to-earnings ratio of about 42.7. The P/E ratio compares a company's share price to its earnings per share.